{"lastClose": 1.7400000095367432, "len": 464, "date": "2023-02-17", "alpha_1": -0.537818539952873, "beta_1": 2.495158148440951, "drawup_1": 0.6999999674883763, "natr_1": 26.59219847867127, "sup_1": -0.429118773421371, "res_1": 0.29693485513810536, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 52.89575213160226, "adx_1": 30.880094436192937, "drawdown_1": -0.6923076997327492, "stratHoldSharpe_1": -0.6077695591117104, "stratHoldAlpha_1": 250.4817387091838, "stratHoldDrawdown_1": -0.6230769297594743, "alpha_3mo": 0.008484081120009535, "beta_3mo": 2.4283549821149775, "drawup_3mo": 0.44078952940877514, "sharpe_3mo": -0.5610151006686771, "natr_3mo": 26.59219847867127, "sup_3mo": -0.0938697331132391, "res_3mo": 0.09961685403763465, "bullPattern_3mo": ["DOJI", "HIKKAKE", "LONGLEGGEDDOJI"], "bearPattern_3mo": ["SPINNINGTOP"], "rsi_3mo": 46.36363449175499, "adx_3mo": 17.421417066174268, "drawdown_3mo": -0.24000000953674316, "stratHoldSharpe_3mo": -0.38661201190913624, "stratHoldAlpha_3mo": 250.72184902690398, "stratHoldDrawdown_3mo": -0.2160000085830689, "Sector": "Health Care", "Country": "United States", "Name": "Ginkgo Bioworks Holdings Inc. Class A", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 3572984949, "IPO Year": 2021.0, "alpha%_1": 0.06791282239733668, "beta%_1": 0.9983763645558619, "drawup%_1": 0.6553588565698196, "natr%_1": 1.0, "drawdown%_1": 0.05671556464898855, "stratHoldSharpe%_1": 0.14315710812702837, "stratHoldAlpha%_1": 0.012502008411486678, "stratHoldDrawdown%_1": 0.06304990225093915, "alpha%_3mo": 0.268906075028149, "beta%_3mo": 0.9955597992029873, "drawup%_3mo": 0.858849476713074, "sharpe%_3mo": 0.03629597941167401, "natr%_3mo": 1.0, "drawdown%_3mo": 0.1139239854375419, "stratHoldSharpe%_3mo": 0.20333188706065236, "stratHoldAlpha%_3mo": 0.1496042184022517, "stratHoldDrawdown%_3mo": 0.11935574114139275}